Allied Healthcare Products Return on Equity

Allied Healthcare Products (AHPIQ) currently reports a ROE of -104.15%. That is below the Healthcare sector average of 13.26%. Use the charts on this page to explore Allied Healthcare Products's ROE history and peer comparisons.

Allied Healthcare Products's ROE of -104.15% is lower than the Healthcare sector average of 13.26%. That is roughly 885.3% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Allied Healthcare Products's current -104.15% should be judged against Healthcare norms (sector average: 13.26%) and against AHPIQ's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -104.15%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.26%. From there, open related valuation or income-statement pages for Allied Healthcare Products, and consider following AHPIQ for alerts when major investors trade the stock.

Allied Healthcare Products is classified in the Healthcare sector. On ROE, it currently shows -104.15% versus a sector average near 13.26%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AHPIQ with unrelated industries.